Migdal Insurance & Financial Holdings’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,000	Closed	-$44K	–	651
2021 Q4	$44K	Buy	+1,000	New	+$47.3K	﹤0.01%	474

Other funds holding IDNA

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Migdal Insurance & Financial Holdings's IDNA Position: Q1 2022 in Review

Migdal Insurance & Financial Holdings sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q1 2022, closing a stake of 1,000 shares — an estimated $44K sold.

Migdal Insurance & Financial Holdings first reported a position in IDNA in Q4 2021 and held it in 1 quarter. The position peaked at $44K in Q4 2021. 86 funds tracked by Wall St. Rank hold IDNA as of Q1 2022.

Migdal Insurance & Financial Holdings reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q1 2022 after selling out during the quarter.
Migdal Insurance & Financial Holdings sold 1,000 iShares Genomics Immunology and Healthcare ETF shares in Q1 2022, an estimated $44K.
Migdal Insurance & Financial Holdings first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2021 and held it in 1 quarter.
Migdal Insurance & Financial Holdings's iShares Genomics Immunology and Healthcare ETF position peaked at $44K in Q4 2021.
86 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2022.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q1 2022, filed 2 May 2022.